DGX
Quest Diagnostics Inc
Services-Medical Laboratories- 売上
- $11.0bn
- 時価総額
- $26.0bn
株価 $234.30 · 100株 2万円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $9.3bn | $9.9bn | $11.0bn |
| 成長率 | — | 6.7% | 11.8% |
| 総利益 | $3.6bn | $3.6bn | $3.6bn |
| 総利益率 | 39.3% | 36.8% | 32.9% |
| 販管費 | $1.6bn | $1.8bn | $2.0bn |
| 販管費率 | 17.7% | 17.9% | 17.8% |
| 営利 | $1.3bn | $1.3bn | $1.6bn |
| 営利率 | 13.6% | 13.6% | 14.1% |
| 純利益 | $854m | $871m | $992m |
| PBR | 4.1 | 3.8 | 3.6 |
| PSR | 2.8 | 2.6 | 2.4 |
| PGPR | 7.2 | 7.2 | 7.2 |
| PER | 30 | 30 | 26 |
| ﾈｯﾄｷｬｯｼｭ | ▲$3.7bn | ▲$5.1bn | ▲$4.7bn |
| EV/EBITDA | 17.5 | 16.9 | 14.5 |
| Rule of 40 | — | 20% | 26% |
| セールス効率 | — | 0% | 0% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）